Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Change in Working Capital
Meridian Bioscience Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Change in Working Capital
$7.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Change in Working Capital
-$102m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-21%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Change in Working Capital
-$55m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Change in Working Capital
-$7.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Change in Working Capital
-$173.3m
|
CAGR 3-Years
-137%
|
CAGR 5-Years
-122%
|
CAGR 10-Years
-21%
|
See Also
What is Meridian Bioscience Inc's Change in Working Capital?
Change in Working Capital
7.6m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Change in Working Capital amounts to 7.6m USD.